Holen Sie sich die Stockscreener-App
6.8201
0.44%
-0.0299
Handel nachbörslich:
6.82
-0.000100
-0.00%
Schlusskurs vom Vortag:
$6.85
Offen:
$6.88
24-Stunden-Volumen:
1,215
Relative Volume:
0.17
Marktkapitalisierung:
$60.89M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-0.58%
1M Leistung:
-0.44%
6M Leistung:
-7.21%
1J Leistung:
+28.92%
1-Tages-Spanne:
$6.8101
$6.88
1-Wochen-Bereich:
$6.81
$6.88
52-Wochen-Spanne:
$3.79
$7.66
Neuehealth Inc Stock (NEUE) Company Profile
Firmenname
Neuehealth Inc
Sektor
Branche
Telefon
612-238-1321
Adresse
9250 NW 36TH STREET, DORAL
Vergleichen Sie NEUE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NEUE
Neuehealth Inc
|
6.8201 | 61.16M | 0 | 0 | 0 | 0.00 |
|
UNH
Unitedhealth Group Inc
|
292.51 | 258.65B | 410.06B | 22.11B | 24.86B | 23.88 |
|
CI
Cigna Group
|
304.34 | 80.16B | 254.47B | 5.03B | 6.01B | 18.06 |
|
CVS
Cvs Health Corp
|
61.85 | 77.27B | 378.96B | 5.28B | 5.94B | 4.19 |
|
ELV
Elevance Health Inc
|
296.60 | 63.44B | 189.25B | 5.36B | 5.34B | 23.50 |
|
HUM
Humana Inc
|
237.12 | 27.89B | 117.76B | 1.21B | 2.39B | 9.95 |
Neuehealth Inc Stock (NEUE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-10-11 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2022-03-29 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-03-04 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-03-02 | Herabstufung | BofA Securities | Buy → Underperform |
| 2022-01-10 | Fortgesetzt | Citigroup | Neutral |
| 2021-12-16 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2021-12-14 | Eingeleitet | Goldman | Neutral |
| 2021-12-10 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2021-11-12 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-11-02 | Herabstufung | Cowen | Outperform → Market Perform |
| 2021-11-01 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-09-10 | Eingeleitet | Cowen | Outperform |
| 2021-08-04 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-08-04 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-07-19 | Eingeleitet | Goldman | Buy |
| 2021-07-19 | Eingeleitet | JP Morgan | Neutral |
| 2021-07-19 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-07-19 | Eingeleitet | Piper Sandler | Overweight |
| 2021-07-19 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-07-19 | Eingeleitet | Wolfe Research | Peer Perform |
Alle ansehen
Neuehealth Inc Aktie (NEUE) Neueste Nachrichten
Is NeueHealth Inc. a good long term investmentHigh-yield capital appreciation - jammulinksnews.com
What analysts say about NeueHealth Inc. stockHigh-velocity gains - jammulinksnews.com
What drives NeueHealth Inc. stock priceFree Stock Market Forecast Reports - jammulinksnews.com
NeueHealth Inc. Stock Analysis and ForecastBreakthrough financial growth - jammulinksnews.com
NeueHealth Q4 Net Loss Narrows, Stock Up In Pre-market - 富途牛牛
NeueHealth to Host Second Quarter 2025 Earnings Conference Call on August 7, 2025 - Business Wire
Why NeueHealth Inc. stock attracts strong analyst attentionLow Risk High Reward Picks - Newser
What makes NeueHealth Inc. stock price move sharplyFree Access to Group - Newser
How NeueHealth Inc. stock performs during market volatilityLow Risk Trade Timing Signals - Newser
NeueHealth Stock Soars Toward 9-Month Highs On $1.3B Take-Private Deal: Retail Exuberant - MSN
NeueHealth (NYSE:NEUE) and Oncology Institute (NASDAQ:TOI) Head to Head Comparison - Defense World
Northern Trust Corp Increases Stock Position in NeueHealth, Inc. (NYSE:NEUE) - Defense World
NeueHealth Inc Holds Annual Stockholders Meeting - TipRanks
NeueHealth (NYSE:NEUE) Trading Down 2% – What’s Next? - Defense World
How Bright Health went from insurtech darling to cautionary tale - Modern Healthcare
NeueHealth's Q1 2025: Key Contradictions in Consumer Growth, Revenue, and Profitability - AInvest
After spinoff, 3M is no longer one of Minnesota’s five largest public companies - Star Tribune
neueHealth CFO Matushak sells $3,190 in common stock - Investing.com Australia
neueHealth CFO Matushak sells $3,190 in common stock By Investing.com - Investing.com Nigeria
NeueHealth Inc. Reports Strong Start to 2025 - TipRanks
UnitedHealth’s financial miscues, and an $800 million revenue cycle bonanza - statnews.com
NeueHealth, Inc. SEC 10-Q Report - TradingView
NeueHealth Q1 2025 slides: improved margins offset revenue decline - Investing.com
NeueHealth: Q1 Earnings Snapshot - New Haven Register
Finanzdaten der Neuehealth Inc-Aktie (NEUE)
Es liegen keine Finanzdaten für Neuehealth Inc (NEUE) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
2.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):